𝔖 Bobbio Scriptorium

✦ LIBER ✦

Opioid-sparing properties of intranasal ketorolac: a pooled analysis of patients experiencing moderate-to-severe acute pain

✍ Scribed by L. Bynum; C. Du Mond

Book ID: 118476812
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 39 KB
Volume: 11
Category: Article
ISSN: 1528-8447
DOI: 10.1016/j.jpain.2010.01.152

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of OPANA ER (Oxymorp

Efficacy and Safety of OPANA ER (Oxymorphone Extended Release) for Relief of Moderate to Severe Chronic Low Back Pain in Opioid-Experienced Patients: A 12-Week, Randomized, Double-blind, Placebo-controlled Study

✍ Martin E. Hale; Harry Ahdieh; Tina Ma; Richard Rauck 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 317 KB

Secukinumab efficacy in subjects with mo

Secukinumab efficacy in subjects with moderate to severe plaque psoriasis: A pooled analysis of patient-reported symptoms (pruritus, pain, and scaling) in 2 phase 3 clinical studies (ERASURE and FIXTURE)

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Quality of life benefits and cost impact

Quality of life benefits and cost impact of prolonged release oxycodone/naloxone versus prolonged release oxycodone in patients with moderate-to-severe non-malignant pain and opioid-induced constipation: a UK cost-utility analysis

✍ Dunlop, William; Uhl, Reiner; Khan, Iftekhar; Taylor, Anna; Barton, Garry 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 504 KB

Quality of Life Benefits and Cost Impact

Quality of Life Benefits and Cost Impact of Prolonged Release Oxycodone/Naloxone Versus Prolonged Release Oxycodone in Patients with Moderate to Severe Pain and Opioid-Induced Constipation Despite the Use of 2 Laxatives: A UK Cost Utility Analysis

✍ Dunlop, W.; Neufeld, K. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB